INTRODUCTION: Up to the present, EGF 61 A/G, TGF-beta1 -509 T/C, and VEGF 936 T/C gene polymorphisms have been analyzed in other cancer entities than colorectal cancer. We have now investigated the frequency of these gene polymorphisms among colorectal cancer patients. MATERIAL AND METHODS: A total of 157 colorectal cancer patients and 117 cancer-free healthy people were recruited at the Surgical Department of the Universitätsklinikum Mannheim. All patients and healthy people are Caucasians. Genomic DNA was isolated from peripheral blood, and gene polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: The distribution of EGF 61 G/G homozygotes among colorectal cancer patients was more frequent than that in the control group (33.1% versus 11.1%; Odds Ratio [OR]=3.962; 95% Confidence Interval [CI]=2.036-7.708). The frequency of the "G" allele in the colorectal cancer patient group was also higher than that in the control group (51.3% versus 33.3%; OR=2.105; 95% CI=1.482-2.988). No difference could be found for the TGF-beta1 and VEGF genotypes among colorectal cancer patients and healthy controls. CONCLUSIONS: The EGF 61 G/G genotype and the G allele are significantly related to colorectal cancer. The TGF-beta1 -509 T/C and VEGF 936 T/C gene polymorphisms are not related to colorectal cancer.
INTRODUCTION: Up to the present, EGF 61 A/G, TGF-beta1-509 T/C, and VEGF 936 T/C gene polymorphisms have been analyzed in other cancer entities than colorectal cancer. We have now investigated the frequency of these gene polymorphisms among colorectal cancerpatients. MATERIAL AND METHODS: A total of 157 colorectal cancerpatients and 117 cancer-free healthy people were recruited at the Surgical Department of the Universitätsklinikum Mannheim. All patients and healthy people are Caucasians. Genomic DNA was isolated from peripheral blood, and gene polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: The distribution of EGF 61 G/G homozygotes among colorectal cancerpatients was more frequent than that in the control group (33.1% versus 11.1%; Odds Ratio [OR]=3.962; 95% Confidence Interval [CI]=2.036-7.708). The frequency of the "G" allele in the colorectal cancerpatient group was also higher than that in the control group (51.3% versus 33.3%; OR=2.105; 95% CI=1.482-2.988). No difference could be found for the TGF-beta1 and VEGF genotypes among colorectal cancerpatients and healthy controls. CONCLUSIONS: The EGF 61 G/G genotype and the G allele are significantly related to colorectal cancer. The TGF-beta1-509 T/C and VEGF 936 T/C gene polymorphisms are not related to colorectal cancer.
Authors: Majid Shahbazi; Vera Pravica; Najma Nasreen; Hana Fakhoury; Anthony A Fryer; Richard C Strange; Peter E Hutchinson; Joy E Osborne; John T Lear; Andrew G Smith; Ian V Hutchinson Journal: Lancet Date: 2002-02-02 Impact factor: 79.321
Authors: Kandace L Amend; James T Elder; Lynn P Tomsho; Joseph D Bonner; Timothy M Johnson; Jennifer Schwartz; Marianne Berwick; Stephen B Gruber Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector Journal: Hum Mol Genet Date: 1999-01 Impact factor: 6.150
Authors: Joana Vieira de Castro; Céline S Gonçalves; Sandra Costa; Paulo Linhares; Rui Vaz; Ricardo Nabiço; Júlia Amorim; Marta Viana-Pereira; Rui M Reis; Bruno M Costa Journal: Tumour Biol Date: 2015-03-27
Authors: A Daraei; R Salehi; M Salehi; M H Emami; M Janghorbani; M Jonghorbani; F Mohamadhashem; H Tavakoli Journal: Med Oncol Date: 2011-05-13 Impact factor: 3.064
Authors: Ramon Andrade de Mello; Mónica Ferreira; Sandra Costa; Bruno Marques Costa; Filipa Soares Pires; Inês Neves; Maria Inês Almeida; João Cunha; Pedro Oliveira; Venceslau Hespanhol; Rui Manuel Reis Journal: Tumour Biol Date: 2012-03-29